Clinical Trials Directory

Trials / Completed

CompletedNCT04172688

Effect of Prebiotics on Function and Pain in Patients with Osteoarthritis and Obesity

Effect of Prebiotics on Function and Pain in Patients with Knee Osteoarthritis and Obesity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
University of Calgary · Academic / Other
Sex
All
Age
30 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of the present study is to determine if prebiotic supplementation can, through changes in the intestinal gut microbiota, lead to improvements in knee function and physical performance and reduce knee pain in adults with obesity and idiopathic metabolic knee osteoarthritis. We hypothesize that prebiotics will reduce systemic and local (knee joint) inflammation, thus improving knee function, lower pain medication use, and enhance performance of daily life activities.

Detailed description

Primary outcome: 1\. To determine the change in knee joint function and physical performance in adults with obesity and knee osteoarthritis treated for 6 months with oligofructose-enriched inulin or placebo. Secondary outcomes: 1. To determine the change in knee pain in adults with obesity and knee osteoarthritis treated for 6 months with oligofructose-enriched inulin or placebo. 2. To examine the change in body composition (fat mass and lean mass) in participants treated with oligofructose-enriched inulin or placebo. 3. To evaluate the change in quality of life in participants treated with oligofructose-enriched inulin or placebo. 4. To gain a mechanistic understanding of the influence of oligofructose-enriched inulin supplementation in metabolic OA through examination of gut microbiota composition and short-chain fatty acid concentrations. 5. To gain a mechanistic understanding of the influence of oligofructose-enriched inulin supplementation in metabolic OA through examination of serum inflammatory and metabolomics markers.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPrebiotic oligofructose-enriched inulinSynergy1
DIETARY_SUPPLEMENTPlacebo maltodextrinEquicaloric dose of maltodextrin

Timeline

Start date
2018-11-18
Primary completion
2021-10-01
Completion
2022-10-30
First posted
2019-11-21
Last updated
2024-12-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04172688. Inclusion in this directory is not an endorsement.